Newly Approved Insomnia Drug Bests Zolpidem in Phase 3

Lemborexant (Dayvigo, Eisai) emerged superior to placebo and to a commonly prescribed medication, zolpidem tartrate extended release (Ambien CR, sanofi-aventis), in a […]

Read More
Tags: , , , , , , , Comments Off on Newly Approved Insomnia Drug Bests Zolpidem in Phase 3